Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy. Maron MS, Masri A, Choudhury L, Olivotto I, et al. J Am Coll Cardiol 2023;81:34-45.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maron MS, Masri A, Choudhury L, Olivotto I, et al. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2023;81:34-45.
PMID: 36599608